Fennec Pharmaceuticals (FENC) Profit After Tax (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Profit After Tax came in at -$4.8 million in Q4 2025, down 141.16% YoY from $11.6 million in Q4 2024, and down 650.31% on a QoQ basis from -$638000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Profit After Tax (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Profit After Tax data on file, last reported at -$4.8 million in Q4 2025.
- Quarterly Profit After Tax fell 141.16% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.7 million (down 2134.4% YoY) and the FY2025 annual result came in at -$9.7 million, down 2134.17% from the prior year.
- Profit After Tax declined to -$4.8 million in Q4 2025, from -$638000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $12.8 million in Q1 2024 to a low of -$8.0 million in Q3 2022.
- A 5-year average of -$3.3 million and a median of -$4.2 million in 2021 frame the typical range for Profit After Tax.
- The widest YoY moves for Profit After Tax: up 312.11% in 2024, down 207.18% in 2024.
- Tracing FENC's Profit After Tax over 5 years: stood at -$4.3 million in 2021, then plunged by 58.04% to -$6.7 million in 2022, then surged by 60.12% to -$2.7 million in 2023, then advanced by 25.99% to -$2.0 million in 2024, then sank by 141.16% to -$4.8 million in 2025.
- The last three Profit After Tax figures came in at -$4.8 million (Q4 2025), -$638000.0 (Q3 2025), and -$3.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97 Mn |
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | -638,000.00 |
| Jun 30, 2025 | -3.15 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | -1.99 Mn |
| Sep 30, 2024 | -5.74 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Mar 31, 2024 | 12.84 Mn |
| Dec 31, 2023 | -2.68 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | -5.44 Mn |
| Mar 31, 2023 | -6.05 Mn |
| Dec 31, 2022 | -6.73 Mn |
| Sep 30, 2022 | -8.05 Mn |
| Jun 30, 2022 | -5.06 Mn |
| Mar 31, 2022 | -3.60 Mn |
| Dec 31, 2021 | -4.26 Mn |
| Sep 30, 2021 | -4.22 Mn |
| Jun 30, 2021 | -3.96 Mn |